Macao–Malaysia Tech & Trade Push: Macau Chief Executive Sam Hou Fai wrapped a Kuala Lumpur leg of his Southeast Asia trip, urging businesses to use Macau and Hengqin’s Greater Bay Area links to reach ASEAN and mainland markets, as the government hosted a seminar with 120+ business matchings and 60+ signed deals across tourism, MICE, high-tech & AI, TCM/big health, and Muslim-friendly initiatives. Autonomous Driving Law Watch: Hong Kong’s LegCo Transport panel visited Beijing to study autonomous driving legislation and testing, including rides in Didi’s autonomous demo zone—signals for future local policy direction. Agentverse Wireless Upgrade: Huawei’s SingleRAN 22.1 launch targets the “Agentverse,” aiming to support mobile AI agents with higher uplink capacity and low-latency service needs. Healthcare Innovation for Greater China: Milestone Pharmaceuticals’ etripamil nasal spray won China NMPA approval for PSVT, with Everest Medicines holding exclusive Greater China rights (including Macau). Cancer Drug Deal With Macau Link: GSK struck a up-to-$1.3B licensing deal with Hutchmed for HMPL-A830, an EGFR–KRAS antibody-targeted therapy conjugate, with Hutchmed retaining control in mainland China, Hong Kong, Macau and Taiwan. Macau Tourism Operations: “Leisure Tour Bus 2.0” carried nearly 37,000 passengers by mid-August; authorities are studying whether to make the service permanent after weekend crowding eased. New Macau Startup Product: Macau Ke Hon Technology launched KEHON RING, a screenless wellness wearable built for global B2B distribution with a lifetime zero-subscription model.